Europe — EMA
Palexia Sr (Tapentadol Hydrochloride)
Tapentadol, the active ingredient in Palexia Sr, is an opioid analgesic presented as a unknown strength/tablet for oral use. It is indicated for the management of moderate to severe acute pain in adult patients.
International sale not permitted. Listed for the domestic market and B2B only.
Request sourcing
What is Tapentadol Hydrochloride?
Tapentadol, the active ingredient in Palexia Sr, is an opioid analgesic presented as a unknown strength/tablet for oral use. It is indicated for the management of moderate to severe acute pain in adult patients.
GNH USA supplies Palexia Sr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Tapentadol Hydrochloride used for?
Tapentadol is an opioid analgesic that acts on the central nervous system. - Acute postoperative pain: Provides relief of pain following surgical procedures. - Chronic musculoskeletal pain: Helps to manage the long‑term pain of conditions such as low back or osteoarthritis. - Cancer‑related pain: t
What are the side effects of Tapentadol Hydrochloride?
Intro
Common -
What precautions apply to Tapentadol Hydrochloride?
Intro
Product details
Related products

Nucynta 50 mg/1
Tapentadol Hydrochloride · 50 mg

Nucynta 50 mg/1
Tapentadol Hydrochloride · 50 mg

Nucynta ER 50 mg/1
Tapentadol Hydrochloride · 50 mg

Nucynta ER 50 mg/1
Tapentadol Hydrochloride · 50 mg